Landscapes / Targets
mineralocorticoid receptor
5 drugs act on mineralocorticoid receptor, in 9 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Mineralocorticoid receptor antagonist |
Approved | 10 Apr 2027Phase 3 trial completes | |||
| How it works | Blocks aldosterone | ||||
| Next date | 10 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Chronic Kidney Disease, Proteinuria and 3 more | ||||
| Open drug page | |||||
Aldosterone antagonist |
Approved | Jun 2028Phase 4 trial completes | |||
| How it works | Blocks aldosterone | ||||
| Next date | Jun 2028 · Phase 4 trial completes | ||||
| Also tested for | Edema Due to Heart Failure or Cirrhosis | ||||
| Open drug page | |||||
— |
Approved | Sep 2028Phase 4 trial completes | |||
| Next date | Sep 2028 · Phase 4 trial completes | ||||
| Also tested for | Duchenne Muscular Dystrophy | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 3 | 16 Apr 2027Phase 3 trial completes | ||
| Next date | 16 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Heart Failure and Impaired Kidney Function, Renal Insufficiency, Chronic | ||||
| Open drug page | |||||
Hydrocortisone acetatenot checked |
Corticosteroid |
Phase 2 | Jan 2027Phase 2 trial completes | ||
| How it works | A steroid that calms inflammation and the immune system | ||||
| Next date | Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Hemorrhoidal Disease | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 5 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026